Minimal residual disease testing measures the presence of residual cancer cells in bone marrow or blood, which is crucial for monitoring treatment response in leukemia patients. We use flow cytometry to ensure accurate and reliable results.
Bone marrow or whole blood/EDTA. Ship immediately at room temperature. Clinical data, fill out form R-5. 4-042 Minimal Residual Disease Questionnaire. Mandatory requirement: prior Initial Immunophenotype study; send a copy of the result.
Muestra
Bone marrow or whole blood/EDTA
Resultados
Your results will be available in 4 to 5 business days
.jpeg){kind=avatar}
